过去一年中添加的文章，按日期排序
[PDF][PDF] Influenza & COVID-19 Vaccine Associated Severe Immune Thrombocytopenia
S Shams, MD Usman Hamayoun, ZS MS III, P Patel - researchgate.net
35 天前 - … the covid-19 and influenza vaccine together It is still undetermined if … vaccines
together [3]. Here, we report a case of secondary ITP following influenza and covid-19 vaccination…
together [3]. Here, we report a case of secondary ITP following influenza and covid-19 vaccination…
Harnessing innate immunity to enhance the quality of adaptive vaccine responses
J Hirsiger - 2024 - edoc.unibas.ch
35 天前 - … with inadvertent influenza vaccine injection into the shoulder joint or bursae
causing shoulder injury related to vaccine administration (SIRVA). We illustrate how vaccine …
causing shoulder injury related to vaccine administration (SIRVA). We illustrate how vaccine …
Baseline immunotypes and immune entropy are indicators of multiple vaccine responsiveness
36 天前 - … in 95 antibody responses to different vaccines between … in the same vaccine response
quartile across three vaccines. … on the response to influenza vaccination in comparison to …
quartile across three vaccines. … on the response to influenza vaccination in comparison to …
[HTML][HTML] … vivo evaluation of a candidate fusion epitopic construct vaccine based on M2e, HA1, HA2, NA and NP fragments of the high pathogenic avian H5N1 influenza …
A Hamidi, H Farzin, A Haghparast - Archives of Razi Institute, 2024 - journals.areeo.ac.ir
36 天前 - … , and the need to develop new vaccines with a wide range of … vaccines using the
conserved peptide of influenza viruses. … a highly significant IgG antibody response following SC …
conserved peptide of influenza viruses. … a highly significant IgG antibody response following SC …
A chimeric haemagglutinin-based universal influenza virus vaccine boosts human cellular immune responses directed towards the conserved haemagglutinin stalk …
38 天前 - … conducted globally to develop optimised universal influenza virus vaccines, (ii) the
… our understanding of correlates of protection for influenza vaccines is a strategic priority for …
… our understanding of correlates of protection for influenza vaccines is a strategic priority for …
Obesity and Respiratory Infections Including COVID-19
P Mancuso - Obesity and Lung Disease: A Guide to …, 2024 - Springer
38 天前 - … titers in obese mice, the levels of antibodies were still below the levels … antibody
titers, adjuvants added to influenza vaccines did not protect obese mice from influenza virus …
titers, adjuvants added to influenza vaccines did not protect obese mice from influenza virus …
Timing of Assessment of Humoral and Cell-Mediated Immunity after Influenza Vaccination
N Otani, K Nakajima, K Yamada, K Ishikawa, K Ichiki… - Vaccines, 2024 - mdpi.com
38 天前 - … Abstract: Assessment of the immune response to influenza vaccines should include
an assessment of both humoral and cell-mediated immunity. However, there is a lack of …
an assessment of both humoral and cell-mediated immunity. However, there is a lack of …
Immunogenicity and protective efficacy of an influenza virus-like particle-based SARS-CoV-2 hybrid vaccine candidate in rhesus macaques
41 天前 - … FluVLP-RBD hybrid vaccine induced a strong antibody response against
influenza-A/PR8 … influenza-A/PR8-VLP. However, we could not test the protective ability against …
influenza-A/PR8 … influenza-A/PR8-VLP. However, we could not test the protective ability against …
Design, Synthesis, and Biological Evaluation of New 2, 6, 7-Substituted Purine Derivatives as Toll-like Receptor 7 Agonists for Intranasal Vaccine Adjuvants
M Kim, K Noh, P Kim, JH Kim, BW Choi… - Journal of Medicinal …, 2024 - ACS Publications
41 天前 - … vaccine efficacy against influenza A virus in vivo. Assessment of humoral and
mucosal antibody … against both homologous and heterologous influenza viral infections. These …
mucosal antibody … against both homologous and heterologous influenza viral infections. These …
Immunogenicity of a seasonal influenza and a pneumococcal polysaccharide vaccine in multiple sclerosis patients under disease modifying therapies: A single-center …
T Marantos, E Kyriazopoulou, E Angelakis, D Kitsos… - Vaccine, 2024 - Elsevier
41 天前 - … Thus, it is difficult to assess effect of time since last dose of specific DMTs on
antibody response. This would require a much larger study sample. Additionally, more data is …
antibody response. This would require a much larger study sample. Additionally, more data is …